August 22, 2019
Teva Pharmaceutical Industries Ltd. didn't infringe a trio of patents related to an anti-rosacea cream produced by Nestle's skin care unit because the patents covered a previously disclosed treatment, a Delaware federal judge ruled Wednesday.